SUPN AS OF 05/31/2012

Company

SUPERNUS PHARMACEUTICALS, INC.

Filed

June 8, 2012

Accession Number

0000080255-12-000569

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →